Dow sets new intraday record as Moderna vaccine progress bolsters market’s least-loved shares

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 97%

Business News News

Business Business Latest News,Business Business Headlines

Market's least-loved stocks benefit in vaccine-news-powered rally

Stocks rose Monday after Moderna Inc. said its vaccine candidate proved highly effective in preventing COVID-19 infections, bolstering the least-loved sectors and industries as investors rotated away from shares of companies that thrived in the stay-at-home environment created by the pandemic.

Last week’s rally was inspired after Pfizer and BioNTech SE on Nov. 9 announced that their vaccine candidate was more than 90% effective in preventing COVID-19 infections in a late-stage trial. While tech shares and other stay-at-home beneficiaries lagged last week, hard-hit industries and sectors, including airlines, energy, financials and retail, benefited.

Meanwhile, investors looked past a stalled transition as President Donald Trump continued to refuse to accept the results of the Nov. 3 presidential election. In economic data, the New York Federal Reserve Bank’s Empire State index came in at a reading of 6.3 from 10.5 in October.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

thanks

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines